研究单位：[1]Xuanwu Hospital, Beijing[2]Beijing Hui People''s Hospital,Beijing,Beijing,China,100053[3]The First People''s Hospital of Yunnan Province,Kunming,Yunnan,China,650032[4]You''anmen Hospital,Beijing,Beijing,China,100069[5]The Ninth Medical Center of Chinese PLA General Hospital,Beijing,Beijing,China,100700[6]The 940th Hospital of Joint Logistics Support Force of Chinese PLA,Lanzhou,Gansu,China,730050[7]Guizhou Provincial People''s Hospital,Guiyang,Guizhou,China,550002[8]Affiliated Hospital of Zunyi Medical University,Zunyi,Guizhou,China,563003[9]Tangshan People''s Hospital,Tangshan,Hebei,China,063000[10]The First Hospital of Hebei Medical University,ShijiaZhuang,Heibei,China,050031[11]Inner Mongolia Autonomous Region People''s Hospital,Hohhot,Inner Mongolia,China,010017[12]The Second Affiliated Hospital of Suzhou University,Suzhou,Jiangsu,China,215004[13]The First Hospital of Jilin University,Jilin,Jilin,China,130021[14]Chifeng Municipal Hospital,Chifeng,Neimenggu,China,024000[15]General Hospital of Ningxia Medical University,Yinchuan,Ningxia,China,750004[16]Qilu Hospital of Shandong University,Jinan,Shandong,China,250012[17]The 960th Hospital of Joint Logistics Support Force of Chinese PLA,Jinan,Shandong,China,250031[18]Liaocheng People''s Hospital,Liaocheng,Shandong,China,252000[19]The Second Hospital of Shanxi Medical University,Taiyuan,Shanxi,China,030001
The study aims to develop and validate a prognostic prediction model for adverse outcomes in neurocritical patients receiving enteral nutrition based on key inflammatory and metabolic markers. This model will serve as a clinical tool to help physicians identify high-risk patients and guide individualized nutritional support strategies.
